Drugs / GSK2890457
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01725126 | Feb → Sep 2013 | obesity disorder | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK2890457 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01725126 ↗ |
| Known as | GSK457 | “GSK2890457 (GSK457) is a combination of 4 nutritional agents” PMID 27093610 ↗ Apr 2016 |